Search

everythinglearnresearchcommunity

for

Search:↓

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

The AI system HairComb accurately scores hair loss severity, matching dermatologist assessments.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Alefacept does not effectively treat severe alopecia areata.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Combining oral minoxidil with JAK inhibitors helps regrow hair in severe alopecia areata cases.

People with alopecia areata often have lower vitamin D levels than healthy people.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Hypothyroidism is often linked to the hair loss condition telogen effluvium.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

Combining CGF and microneedling with betamethasone effectively treats resistant alopecia areata.

Calcipotriol cream can effectively and safely treat mild-to-moderate patchy hair loss.

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.

Cryotherapy and steroid injections are similarly effective and safe for treating alopecia areata.